EA000304B1
(ru)
*
|
1995-02-02 |
1999-04-29 |
Смитклайн Бичам Плс |
Производные индола как антагонисты рецептора 5-ht
|
GB9517559D0
(en)
*
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
GB9607219D0
(en)
*
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
GB9612885D0
(en)
*
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9612883D0
(en)
*
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
GB9710523D0
(en)
*
|
1997-05-23 |
1997-07-16 |
Smithkline Beecham Plc |
Novel compounds
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
WO1999043650A2
(en)
*
|
1998-02-25 |
1999-09-02 |
Smithkline Beecham Plc |
Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
|
ES2156845T1
(es)
*
|
1998-04-14 |
2001-08-01 |
Arena Pharm Inc |
Receptores de serotonina humana no endogenos constitutivamente activados y moduladores de moleculas pequeñas para estos.
|
US6140509A
(en)
*
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6150393A
(en)
*
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
US7141581B2
(en)
|
1999-07-02 |
2006-11-28 |
Agouron Pharmaceuticals, Inc. |
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
|
EP1200086A4
(en)
*
|
1999-08-04 |
2009-05-27 |
Icagen Inc |
THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
|
AUPQ319899A0
(en)
*
|
1999-10-01 |
1999-10-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
HN2001000008A
(es)
*
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
US20040087798A1
(en)
*
|
2000-03-14 |
2004-05-06 |
Akira Yamada |
Novel amide compounds
|
US6448293B1
(en)
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
FR2807754A1
(fr)
*
|
2000-04-13 |
2001-10-19 |
Adir |
Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
AU2001249865A1
(en)
|
2000-04-18 |
2001-10-30 |
Agouron Pharmaceuticals, Inc. |
Pyrazoles for inhibiting protein kinase
|
GB0019950D0
(en)
*
|
2000-08-12 |
2000-09-27 |
Smithkline Beecham Plc |
Compounds
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
US6630504B2
(en)
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
US6610747B2
(en)
|
2000-08-31 |
2003-08-26 |
Pfizer Inc. |
Phenoxybenzylamine derivatives as SSRIs
|
JP4160295B2
(ja)
*
|
2000-12-08 |
2008-10-01 |
武田薬品工業株式会社 |
3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
|
US7067539B2
(en)
|
2001-02-08 |
2006-06-27 |
Schering Corporation |
Cannabinoid receptor ligands
|
US7507767B2
(en)
|
2001-02-08 |
2009-03-24 |
Schering Corporation |
Cannabinoid receptor ligands
|
GB2380190A
(en)
*
|
2001-08-28 |
2003-04-02 |
Bayer Ag |
Antiinflammatory heterocyclic sulphones
|
EP1438795B1
(en)
|
2001-09-29 |
2012-02-08 |
LG Electronics, Inc. |
Method for transferring and /or receiving data in communication system and apparatus thereof
|
PL369952A1
(en)
|
2001-11-14 |
2005-05-02 |
Schering Corporation |
Cannabinoid receptor ligands
|
GB0200283D0
(en)
*
|
2002-01-08 |
2002-02-20 |
Smithkline Beecham Plc |
Compounds
|
EP1496896A4
(en)
|
2002-04-08 |
2007-10-31 |
Merck & Co Inc |
AKT INHIBITORS EFFECT
|
AU2003230802B2
(en)
|
2002-04-08 |
2007-08-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
WO2004000807A1
(en)
|
2002-06-19 |
2003-12-31 |
Schering Corporation |
Cannabinoid receptor agonists
|
WO2004004720A1
(en)
*
|
2002-07-03 |
2004-01-15 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
AU2003257145B2
(en)
|
2002-08-02 |
2008-11-13 |
Merck Sharp & Dohme Corp. |
Substituted furo (2,3-b) pyridine derivatives
|
EP1530569A2
(en)
*
|
2002-08-23 |
2005-05-18 |
Rigel Pharmaceuticals, Inc. |
Pyridyl substituted heterocycles useful for treating or preventing hcv infection
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
CA2501365C
(en)
|
2002-10-30 |
2011-05-31 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
WO2004058683A2
(en)
*
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
JP2006511587A
(ja)
*
|
2002-12-20 |
2006-04-06 |
ミジェニックス コーポレイション |
アデニンヌクレオチドトランスロカーゼ(ant)リガンドならびにそれに関連する組成物および方法
|
US20060229335A1
(en)
*
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
CA2522430A1
(en)
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
AU2004233941A1
(en)
*
|
2003-04-25 |
2004-11-11 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
WO2005002673A1
(en)
*
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
MY141862A
(en)
|
2003-07-22 |
2010-07-16 |
Arena Pharm Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
US7517900B2
(en)
|
2003-10-10 |
2009-04-14 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
EP1727803B3
(en)
|
2004-03-23 |
2014-04-23 |
Arena Pharmaceuticals, Inc. |
Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
CA2579002C
(en)
*
|
2004-09-02 |
2012-11-27 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
PE20061130A1
(es)
*
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
US20080015223A1
(en)
*
|
2004-12-03 |
2008-01-17 |
Arena Pharmaceuticals, Inc. |
Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
|
AU2006206687A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
WO2007026920A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
US8217041B2
(en)
|
2005-11-08 |
2012-07-10 |
Laboratories del Sr. Esteve, S.A. |
Indene derivatives, their preparation and use as medicaments
|
EP2018371B1
(en)
|
2006-05-18 |
2015-03-04 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
EP2018372B1
(en)
|
2006-05-18 |
2015-05-13 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
CN101479261A
(zh)
|
2006-05-18 |
2009-07-08 |
艾尼纳制药公司 |
3-吡唑基-苯甲酰胺-4-醚、其仲胺及其衍生物作为5-ht2a血清素受体的调节剂用于治疗与其相关的病症
|
EP2041116A1
(de)
*
|
2006-07-07 |
2009-04-01 |
Boehringer Ingelheim International GmbH |
Phenyl substituierte heteroaryl-derivate und deren verwendung als antitumormittel
|
EP1884515A1
(en)
|
2006-07-31 |
2008-02-06 |
Laboratorios del Dr. Esteve S.A. |
Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
WO2008058341A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Cytopia Research Pty Ltd |
Inhibitors of kinase activity
|
US9187485B2
(en)
|
2007-02-02 |
2015-11-17 |
Baylor College Of Medicine |
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
|
CN103450077B
(zh)
|
2007-06-08 |
2016-07-06 |
满康德股份有限公司 |
IRE-1α抑制剂
|
CA2692379A1
(en)
*
|
2007-07-02 |
2009-01-08 |
Boehringer Ingelheim International Gmbh |
Antiproliferative compounds based on 5-membered heterocycles
|
PE20090837A1
(es)
*
|
2007-07-02 |
2009-07-24 |
Boehringer Ingelheim Int |
Nuevos compuestos quimicos
|
ATE499099T1
(de)
|
2007-07-19 |
2011-03-15 |
Esteve Labor Dr |
Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
|
ES2421237T7
(es)
|
2007-08-15 |
2013-09-30 |
Arena Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
CN102227421A
(zh)
|
2008-09-29 |
2011-10-26 |
贝林格尔.英格海姆国际有限公司 |
抗增殖化合物
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
CN104784173B
(zh)
|
2008-10-28 |
2019-07-26 |
艾尼纳制药公司 |
用于治疗5-ht2a5-羟色胺受体相关障碍的5-ht2a5-羟色胺受体调节剂组合物
|
CN102348798A
(zh)
|
2009-01-16 |
2012-02-08 |
麻省理工学院 |
孤独症谱系障碍的诊断和治疗
|
CA2774372A1
(en)
*
|
2009-09-17 |
2011-03-24 |
Vanderbilt University |
Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
WO2011117382A1
(en)
|
2010-03-26 |
2011-09-29 |
Boehringer Ingelheim International Gmbh |
Pyridyltriazoles
|
JP5871896B2
(ja)
|
2010-03-26 |
2016-03-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
B−rafキナーゼインヒビター
|
US9751847B2
(en)
|
2010-10-14 |
2017-09-05 |
University Of Utah Research Foundation |
Methods and compositions related to neuroactive thiazoline compounds
|
US8710055B2
(en)
|
2010-12-21 |
2014-04-29 |
Boehringer Ingelheim International Gmbh |
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
PT2762466T
(pt)
*
|
2011-09-29 |
2017-07-31 |
Ono Pharmaceutical Co |
Derivado de fenilo
|
EP2763532B1
(en)
|
2011-10-05 |
2018-09-19 |
The Board of Trustees of the Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
US9926309B2
(en)
|
2011-10-05 |
2018-03-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
AR094553A1
(es)
|
2013-01-23 |
2015-08-12 |
Astrazeneca Ab |
Formas de oxadiazolpirazina
|
WO2015077246A1
(en)
|
2013-11-19 |
2015-05-28 |
Vanderbilt University |
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mglur5
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
US10022355B2
(en)
|
2015-06-12 |
2018-07-17 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
|
US10421756B2
(en)
|
2015-07-06 |
2019-09-24 |
Rodin Therapeutics, Inc. |
Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase
|
HUE057041T2
(hu)
|
2015-07-06 |
2022-04-28 |
Alkermes Inc |
Hiszton deacetiláz hetero-halogén gátlói
|
BR112018000728A2
(pt)
|
2015-07-15 |
2018-09-04 |
Axovant Sciences Gmbh |
resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ[3,4−d][1,3]オキサジン誘導体、およびbace阻害剤としてのその使用
|
US10300155B2
(en)
|
2015-12-31 |
2019-05-28 |
Washington University |
Alpha-synuclein ligands
|
WO2017147526A1
(en)
|
2016-02-26 |
2017-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
PL3570834T3
(pl)
|
2017-01-11 |
2022-05-23 |
Alkermes, Inc. |
Bicykliczne inhibitory deacetylazy histonowej
|
RS63343B1
(sr)
|
2017-08-07 |
2022-07-29 |
Alkermes Inc |
Biciklični inhibitori histonske deacetilaze
|
CA3089566A1
(en)
|
2018-01-31 |
2019-08-08 |
Deciphera Pharmaceuticals, Llc |
Combination therapy for the treatment of gastrointestinal stromal tumors
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
JP2022544234A
(ja)
|
2019-08-12 |
2022-10-17 |
デシフェラ・ファーマシューティカルズ,エルエルシー |
胃腸間質腫瘍を治療するためのリプレチニブ
|
EP4084778B1
(en)
|
2019-12-30 |
2023-11-01 |
Deciphera Pharmaceuticals, LLC |
Amorphous kinase inhibitor formulations and methods of use thereof
|
KR20220123058A
(ko)
|
2019-12-30 |
2022-09-05 |
데시페라 파마슈티칼스, 엘엘씨. |
1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
|
WO2023114320A1
(en)
*
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Fused pyrrolidine psychoplastogens and uses thereof
|
WO2023114313A1
(en)
*
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
|
WO2023114325A1
(en)
*
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Constrained amine psychoplastogens and uses thereof
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|